Kid Cards: Teaching Kids About Medicines
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00127543 |
|
Recruitment Status : Unknown
Verified December 2005 by Children's Mercy Hospital Kansas City.
Recruitment status was: Active, not recruiting
First Posted : August 8, 2005
Last Update Posted : February 7, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This study is being done to see if education about medicines directed toward children will improve their knowledge. The investigators also want to know if this knowledge lasts over time. Right now there are few medication instructional cards that are appropriate for children. Most of the medication cards provide information for adults. Some studies have shown that by teaching children directly, the children may take medicine at the right time for the right reason, have fewer side effects and know more about their medicine.
The purpose of this research study is to see if education about medication helps children learn more about their medicine and if this knowledge lasts.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Hemophilia Sickle Cell Disease Neoplasms Blood Coagulation Disorders | Behavioral: Medication Education for Children | Not Applicable |
In 2004, then Surgeon General Carmona stated that a health literate individual is more apt to know the answer, when asked how to keep themselves well (AHRQ, 2004). There is a burgeoning movement among medical professionals to address health literacy. Teaching health information to children will empower them to actively participate in their current care and provide self-management skills that will assist them to keep themselves well throughout their lives. Currently, few medication administration instructional cards exist that are appropriate for children. Providing medication information that the child might understand may result in better administration compliance, fewer adverse effects and develop an individual that is knowledgeable regarding medications and appropriate administration. The purpose if this research is to develop medication administration cards, appropriate for children, which provide information on the most commonly used drugs among the Hematology/Oncology population.
The overall objective of this research is to develop medication informational cards for medications frequently used within the Hematology/Oncology pediatric population, and evaluate the effectiveness of these cards, by means of a pre- and post–test.
| Study Type : | Interventional (Clinical Trial) |
| Enrollment : | 50 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Educational/Counseling/Training |
| Official Title: | Kid Cards: Teaching Kids About Medicines |
| Study Start Date : | August 2005 |
| Study Completion Date : | December 2005 |
- Develop medication cards appropriate for children
- Develop a post-test to determine the effectiveness
- Obtain data to support teaching children about medication
- Assess the clinical implications of this research
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 7 Years to 11 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Between the ages of 7 – 11 years
- Currently receiving disease management primarily coordinated through the Hematology/Oncology section
- Receiving a medication identified as a variable for this study
- Are able to assent and have a parent/guardian who is willing to consent to study participation
- Suffer no apparent developmental difficulty that would prevent or make study participation difficult
Exclusion Criteria:
- Individuals who cannot read or write English
- Individuals who are known to be non-compliant with medication routine and/or adhering to follow-up visits.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00127543
| United States, Missouri | |
| Childrens Mercy Hospitals and Clinics | |
| Kansas City, Missouri, United States, 64108 | |
| Principal Investigator: | Heather E Curry, RN, MSN | Childrens Mercy Hospitals and Clinics |
| ClinicalTrials.gov Identifier: | NCT00127543 History of Changes |
| Other Study ID Numbers: |
05 06-089E |
| First Posted: | August 8, 2005 Key Record Dates |
| Last Update Posted: | February 7, 2006 |
| Last Verified: | December 2005 |
Keywords provided by Children's Mercy Hospital Kansas City:
|
Medication Education Pediatric |
Additional relevant MeSH terms:
|
Anemia, Sickle Cell Blood Coagulation Disorders Hemostatic Disorders Anemia, Hemolytic, Congenital Anemia, Hemolytic Anemia |
Hematologic Diseases Hemoglobinopathies Genetic Diseases, Inborn Vascular Diseases Cardiovascular Diseases Hemorrhagic Disorders |